Product Name | MF | CAS | Details |
---|
Foslevodopa Impurity 27 | 2837105-88-9 | Details |
Foslevodopa Impurity 29 | 2837107-22-7 | Details |
Foslevodopa Impurity 28 | 2837107-41-0 | Details |
Levodopa Impurity 27 | C11H15NO4 | 37178-37-3 | Details |
Levodopa Impurity 29 | C13H19NO3 | 18822-59-8 | Details |
PACLITAXEL SIDE CHAIN 2 | C25H33NO3Si | 155371-59-8 | Details |
Oxybutynin Impurity 4(Oxybutynin EP Impurity D) | C14H18O3 | 4335-77-7 | Details |
Oxybutynin Impurity 5(Oxybutynin EP Impurity E) | C23H33NO3 | 1215677-72-7 | Details |
Paclitaxel Impurity 20 | C28H29NO5 | 2097541-16-5 | Details |
Axitinib-13C-d3 | C22H15D3N4OS | 1261432-00-1 | Details |
Axitinib Impurity 55 | C7H7N3 | 19335-11-6 | Details |
Oxybutynin Impurity 2(Oxybutynin EP Impurity B) | C22H25NO3 | 14943-53-4 | Details |
Oxybutynin Impurity 3(Oxybutynin EP Impurity C) | C20H28ClNO3 | 70844-58-5 | Details |
N-acetyl-10-deacetyl-N-debenzoylpaclitaxel | C40H47NO13 | 1144034-42-3 | Details |
Axitinib Impurity 46 | C8H9N | 6515-13-5 | Details |
Axitinib Impurity 45 | C15H12IN3O2S | 1443118-71-5 | Details |
Axitinib Impurity 49 | C7H6IN3 | 885519-20-0 | Details |
Axitinib Impurity 52 | C22H18N4OS | 885126-40-9 | Details |
Oxybutynin Impurity 6(Oxybutynin USP RC B) | C15H20O3 | 10399-13-0 | Details |
Oxybutynin Impurity 8 | C20H28ClNO3 | 81039-77-2 | Details |
Oxybutynin-d10 HCl | C22H22ClD10NO3 | 120092-65-1 | Details |
Oxybutynin-d11 HCl | C22H32ClNO3 | 1185151-95-4 | Details |
Oxybutynin Impurity 11 ((S)-Oxybutynin HCl) | C22H32ClNO3 | 230949-16-3 | Details |
Oxybutynin Impurity 13 | C16H22O3 | 31197-69-0 | Details |
Oxybutynin Impurity 15 | C8H15NO | 10575-25-4 | Details |
Oxybutynin Impurity 16 | C20H28ClNO3 | 181647-14-3 | Details |
Oxybutynin Impurity 7 Hydrochloride | C22H32ClNO3 | 1207344-05-5 | Details |
(S)-Oxybutynin | C22H31NO3 | 119618-22-3 | Details |
(R)-DESETHYL OXYBUTYNIN HCL | C20H27NO3 | 181647-19-8 | Details |
DESETHYLOXYBUTYNIN, HYDROCHLORIDE | C20H27NO3 | 80976-67-6 | Details |
Osimertinib Impurity 3 | C22H22N6O3 | 1820891-36-8 | Details |
Osimertinib Impurity 2 | C22H24N6O | 1801616-92-1 | Details |
rac Desethyl Oxybutynin-d5 Hydrochloride | C20H28ClNO3 | 1173147-63-1 | Details |
Oxybutynin IMpurity C | C21H29NO3 | 1199574-70-3 | Details |
Oxybutynin | C22H31NO3 | 5633-20-5 | Details |
Osimertinib Impurity 9 | C25H26N6O2 | 2044702-39-6 | Details |
Osimertinib Impurity 10 | C25H29N7O3 | 1421372-67-9 | Details |
Osimertinib Impurity 11 | C31H35N7O3 | 1932710-29-6 | Details |
Osimertinib Impurity 13 | C28H33N7O4 | 2411395-23-6 | Details |
Osimertinib Impurity 15 | C28H35N7O2 | 2734881-83-3 | Details |
Osimertinib Impurity 18 | C28H34ClN7O2 | Details |
Osimertinib Impurity 19 | C27H31N7O2 | 2226039-64-9 | Details |
Osimertinib Impurity 20 | C23H20FN5O2 | 2213409-62-0 | Details |
Osimertinib Impurity 25 | C21H20N6O3 | 2044704-62-1 | Details |
Osimertinib Impurity 26 (AZ7550) | C27H31N7O2 | 1421373-99-0 | Details |
Osimertinib Impurity 29 | C28H33N7O2 | 2044702-65-8 | Details |
Osimertinib Mesylate | C29H37N7O5S | 1421373-66-1 | Details |
Osimertinib Impurity 4 | C25H30N6O3 | 1009298-59-2 | Details |
Osimertinib Impurity 7 | C30H35N7O2 | 1825287-91-9 | Details |
N-Desmethyl Asenapine-d4 | C16H14ClNO | 128915-56-0 | Details |
Asenapine Impurity 9 | C17H14ClNO2 | 912356-09-3 | Details |
Osimertinib dimesylate | C29H37N7O5S | 2070014-82-1 | Details |
Asenapine Impurity 1 | C17H14ClNO2 | 129385-59-7 | Details |
Asenapine Impurity 2 (Asenapine 11-Hydroxysulfate) | C17H16ClNO5S | 1399103-21-9 | Details |
Asenapine 11-Hydroxysulfate-13C-d3 | C17H16ClNO5S | 1391745-00-8 | Details |
Asenapine Impurity 11 ((R,R)-Asenapine Maleate) | C21H20ClNO5 | 135883-16-8 | Details |
Asenapine Impurity 12 ((S,S)-Asenapine Maleate) | C21H20ClNO5 | 135883-08-8 | Details |
cis-Asenapine Maleate | C21H20ClNO5 | 85650-55-1 | Details |
cis-Asenapine | C17H16ClNO | 1422571-39-8 | Details |
Cis-Asenapine Fumaric Acid | C21H22N2O5 | 1688678-60-5 | Details |
Asenapine Impurity 13(2,3-Dihydro-1-oxo Asenapine) | C17H12ClNO2 | 934996-79-9 | Details |
Asenapine Impurity 18 | C16H12BrClO2 | 1000890-01-6 | Details |
Asenapine Impurity 15 | C17H12ClNO | 129385-60-0 | Details |
N-Desmethyl Asenapine-d4 Hydrochloride | C16H15Cl2NO | 1246820-54-1 | Details |
Asenapine | C17H16ClNO | 65576-45-6 | Details |
N-Desmethyl Asenapine Hydrochloride | C16H15Cl2NO | 1170701-78-6 | Details |
Asenapine Impurity 19 | C17H14ClNO3 | 934996-78-8 | Details |
2,3-Dihydro-1-oxo Asenapine | C17H14ClNO | 27449-95-2 | Details |
Asenapine-d3 | C17H13ClD3NO | 1180843-72-4 | Details |
Asenapine Impurity 21 | C17H17BrClNO | 1000890-02-7 | Details |
Asenapine Impurity 17 | C17H18ClNO | 1688731-74-9 | Details |
11-Hydroxyasenapine-13C-d3 | 1391744-99-2 | Details |
Asenapine Impurity 14(11-Hydroxyasenapine) | C17H16ClNO2 | 1262639-38-2 | Details |
Asenapine-N-Glucuronide-13C-d3 | C23H24ClNO7 | 1391745-10-0 | Details |
Dechloro Asenapine Ethanedioate | C19H19NO5 | 1366179-39-6 | Details |
Asenapine Citrate | C23H24ClNO8 | 1411867-74-7 | Details |
Asenapine Impurity 5 (Cis-Asenapine) | C17H16ClNO | 65621-78-5 | Details |
Asenapine Impurity 6 (Deschloro Asenapine) | C17H17NO | 1847487-56-2 | Details |
Osimertinib Impurity 23 | C13H11N3O | 1896788-06-9 | Details |
Osimertinib Impurity 17 | C18H23N5 | 2227103-40-2 | Details |
Osimertinib Impurity 14 | C27H33N7O2 | 2227103-37-7 | Details |
(S)-DESETHYL OXYBUTYNIN HCL | C20H27NO3 | 181646-98-0 | Details |
Oxybutynin Impurity 8-d11 | C20H28ClNO3 | 1216405-15-0 | Details |
Oxybutynin Impurity 8-d5 | C20H28ClNO3 | 1173018-49-9 | Details |
Oxybutynin Impurity 17 | C20H28ClNO3 | 181647-12-1 | Details |
Oxybutynin Impurity 9 | C22H31NO4 | 80976-68-7 | Details |
Oxybutynin Impurity 7 | C22H31NO3 | 119618-21-2 | Details |
C9H10BrNO | 885956-50-3 | Details |
Levodopa Impurity 21 Hydrate | C10H15NO5 | 200630-46-2 | Details |
Levodopa Impurity 24 | C13H19NO4 | 121770-19-2 | Details |
Levodopa Impurity 28 | C12H17NO4 | 110301-07-0 | Details |
Levodopa Impurity 25 | C13H19NO4 | 39638-52-3 | Details |
Levodopa Impurity 26 | C28H31NO6 | 59727-98-9 | Details |
Asenapine Impurity 20 | C23H22ClNO9 | 128923-28-4 | Details |
Osimertinib Impurity 12 | C28H33N7O3 | 2411395-22-5 | Details |
PACLITAXEL SOLUTION STD 0.5mg/mL(P) | C47H51NO14 | 379688-61-6 | Details |
Asenapine-13C,d3 | C17H16ClNO | 1217729-73-1 | Details |
Asenapine Impurity 10 | C17H10ClNO3 | 129385-61-1 | Details |
(S)-DIMETHYL OXYBUTYNIN HCL | C20H28ClNO3 | 633-20-5 | Details |
PACLITAXEL-(2-BENZOYL RING-UL-14C) | C47H51NO14 | 179795-24-5 | Details |
Product Total: Product Page: | ||||
66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 |